Madrigal Pharmaceuticals Inc

10 de set. de 2026, 20:03 UTC

Madrigal Pharmaceuticals shares are lower as CEO highlights MASH sector potential at the Cantor Fitzgerald conference amid broader market volatility and ECB rate hike effects.

3 de set. de 2026, 19:36 UTC

Madrigal Pharmaceuticals is presenting five abstracts on MASH at the Paris conference on September 10, as shares trade lower today.

2 de set. de 2026, 21:01 UTC

Madrigal Pharmaceuticals is trading lower in after-market hours amid broader market weakness and unusual inactivity, though it remains above its 20-day moving average.

1 de set. de 2026, 19:36 UTC

Madrigal Pharmaceuticals shares are declining amid rising oil prices and inflation concerns. The stock initially reached a session high earlier in the session.

31 de ago. de 2026, 21:01 UTC

Madrigal Pharmaceuticals shares are lower in after-market trading, fluctuating within a narrow range amid broader market sentiment influenced by Fed Chair Kevin Warsh's remarks.

28 de ago. de 2026, 19:56 UTC

Madrigal Pharmaceuticals Inc shares are lower today, with no specific news identified. Broader market sentiment may be affected by inflation concerns from a Federal Reserve official.

27 de ago. de 2026, 21:01 UTC

Madrigal Pharmaceuticals Inc shares are higher in after-market trading, continuing a cumulative gain since Thursday's close, with no specific news identified.

26 de ago. de 2026, 22:01 UTC

Madrigal Pharmaceuticals shares are higher in after-market trading, reaching a peak of 1.05% above Wednesday's close, with no specific news identified.

21 de ago. de 2026, 19:46 UTC

Madrigal Pharmaceuticals is lower in Friday's session, retracing from an earlier peak amid broader market pressures from rising Treasury yields and inflation concerns.

20 de ago. de 2026, 23:46 UTC

Madrigal Pharmaceuticals shares are lower in after-market trading. Broader market declines are attributed to rising crude oil prices and geopolitical tensions.

18 de ago. de 2026, 19:56 UTC

Madrigal Pharmaceuticals shares are lower today amid rising Treasury yields, which may be influencing investor sentiment. Earlier, the stock pulled back from a session high.

17 de ago. de 2026, 19:35 UTC

Madrigal Pharmaceuticals is trading higher today, continuing gains since Friday's close, despite no specific company news driving the upward movement.

14 de ago. de 2026, 19:26 UTC

Madrigal Pharmaceuticals launches a Phase 2a study for resmetirom. Shares are lower today, pulled back from earlier gains amid broader market concerns over retail sales.

13 de ago. de 2026, 21:01 UTC

Madrigal Pharmaceuticals Inc shares are higher in after-market trading, showing notable movement since Thursday's close, though no specific news explains the price action.

12 de ago. de 2026, 21:01 UTC

Madrigal Pharmaceuticals shares are higher in after-market trading. Positive market sentiment follows comments on CPI reports that may impact Federal Reserve interest rate decisions.

10 de ago. de 2026, 19:16 UTC

Madrigal Pharmaceuticals Inc shares are higher, despite no specific news. Broader market conditions reflect a decline in U.S. stock futures amid job data.

7 de ago. de 2026, 20:02 UTC

Madrigal Pharmaceuticals shares are lower during Friday's session, continuing a decline since Thursday. The stock remains below its 20-day moving average.

6 de ago. de 2026, 21:01 UTC

Madrigal Pharmaceuticals granted equity inducement awards to ten new employees, boosting shares modestly higher in after-market trading.

4 de ago. de 2026, 20:04 UTC

Madrigal Pharmaceuticals upgraded to Outperform by Wolfe Research, with a price target of $605. Shares are higher since Monday, despite a pullback earlier today.

3 de ago. de 2026, 19:31 UTC

Madrigal Pharmaceuticals shares are higher as CEO Bill Sibold notes market hesitance toward IVA due to weight gain concerns. The broader market also advances.

31 de jul. de 2026, 23:06 UTC

Madrigal Pharmaceuticals Inc shares are lower in after-market hours with no specific news identified. The stock remains near the lower end of its one-month range.

30 de jul. de 2026, 19:27 UTC

Madrigal Pharmaceuticals shares are lower following a widened second-quarter net loss of $57.9 million and increased operating expenses of $420.6 million.

29 de jul. de 2026, 22:26 UTC

Madrigal Pharmaceuticals shares are lower in after-market hours, reflecting broader market volatility following the Federal Reserve's interest rate decision and inflation concerns.

28 de jul. de 2026, 18:46 UTC

Madrigal Pharmaceuticals is lower today, continuing a broader decline since Monday's close. No specific news has been identified to explain the movement.

27 de jul. de 2026, 23:56 UTC

Madrigal Pharmaceuticals Inc is trading higher in after-market hours, reflecting a notable increase since Monday's close, despite no specific news identified.

20 de jul. de 2026, 16:02 UTC

Madrigal Pharmaceuticals is lower today amid aggressive call buying and heightened market volume, with broader inflation concerns influenced by geopolitical tensions.